$NASDAQ:BIIB

Biogen Inc Offers New Options for Investors with December Expiration Date
Gallery

Biogen Inc Offers New Options for Investors with December Expiration Date

🌥️Trending News Biogen Inc ($NASDAQ:BIIB) is a leading biotechnology company that focuses on the development and delivery of innovative therapies [...]

By GoodWhale|November 9, 2024|Categories: Drug Manufacturers - General|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Forsta AP Fonden Increases Stake in Biogen by 13.8% in Third Quarter
Gallery

Forsta AP Fonden Increases Stake in Biogen by 13.8% in Third Quarter

🌥️Trending News BIOGEN INC ($NASDAQ:BIIB) is a biotechnology company that specializes in the development and production of therapies for serious [...]

By GoodWhale|October 30, 2024|Categories: Drug Manufacturers - General|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Biogen Inc Intrinsic Value – Biogen Named Among Top 10 QQQ Stocks to Buy According to Analysts’ List
Gallery

Biogen Inc Intrinsic Value – Biogen Named Among Top 10 QQQ Stocks to Buy According to Analysts’ List

☀️Trending News Biogen Inc ($NASDAQ:BIIB). is a biotechnology company based in Cambridge, Massachusetts. Biogen is known for its drugs such [...]

By GoodWhale|October 22, 2024|Categories: Drug Manufacturers - General, Intrinsic Value|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Biogen Inc Receives High Analyst Ratings, Boosting Confidence in BIIB Stock
Gallery

Biogen Inc Receives High Analyst Ratings, Boosting Confidence in BIIB Stock

☀️Trending News Biogen Inc ($NASDAQ:BIIB), also known as BIIB, is a biotechnology company that has been making waves in the [...]

By GoodWhale|October 12, 2024|Categories: Drug Manufacturers - General|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Biogen Falls Below Broader Market, Closing at $216.69 in Latest Trading Session
Gallery

Biogen Falls Below Broader Market, Closing at $216.69 in Latest Trading Session

🌥️Trending News Biogen Inc ($NASDAQ:BIIB). is a leading biotechnology company that focuses on developing treatments for neurological and neurodegenerative diseases. [...]

By GoodWhale|March 27, 2024|Categories: Drug Manufacturers - General|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Europe Revokes Approvals for Generics of Biogen’s MS Drug Tecfidera
Gallery

Europe Revokes Approvals for Generics of Biogen’s MS Drug Tecfidera

🌥️Trending News Biogen Inc ($NASDAQ:BIIB). is a biotechnology company based in Cambridge, Massachusetts. The company focuses on the discovery, development, [...]

By GoodWhale|December 20, 2023|Categories: Drug Manufacturers - General|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Biogen Inc Intrinsic Value – Evaluating Biogen’s Performance in the Biotechnology Industry Compared to its Competitors
Gallery

Biogen Inc Intrinsic Value – Evaluating Biogen’s Performance in the Biotechnology Industry Compared to its Competitors

🌥️Trending News Biogen Inc ($NASDAQ:BIIB). is a leading biotechnology company headquartered in Cambridge, Massachusetts, USA. It is considered one of [...]

By GoodWhale|December 15, 2023|Categories: Drug Manufacturers - General, Intrinsic Value|Tags: $NASDAQ:BIIB, Drug Manufacturers - General, NASDAQ|0 Comments

Biogen Inc Stock Fair Value – Biogen and Eisai Partner to Introduce Revolutionary Alzheimer’s Therapy in Japan
Gallery

Biogen Inc Stock Fair Value – Biogen and Eisai Partner to Introduce Revolutionary Alzheimer’s Therapy in Japan

🌥️Trending News Biogen Inc ($NASDAQ:BIIB)., a Massachusetts-based global biotechnology company, is set to partner with Japanese pharmaceutical firm Eisai to [...]